Collaborations

• Immunohematology and Cell Therapy, Transfusion Medicine Department, Meyer University Hospital (Azienda Ospedaliero-Universitaria Meyer), Florence, Italy
• Veneto Eye Bank Foundation, Venice, Italy
• IRCCS Ca’ Granda Foundation, Cell Factory Ospedale Maggiore Policlinico, Milan, Italy
• Laboratory of Cell Biology and Advanced Cancer Therapy, Oncology-Hematology Department, University of Modena and Reggio Emilia, Italy
• Stem Cell Research Lab, Section of Hematology, Department of Medicine, University of Verona, Italy
• High-Throughput Screening core facility (CIBIO), University of Trento, Italy
• Oncological Reference Center in Aviano (PN), Italy
• Department of Pharmaceutical sciences, University of Padua, Italy
• Andalusian Initiative for Advanced Therapies, Seville, Spain
• Universitätsklinikum, Department of Internal Medicine II, Wuerzburg, Germany
• Centre for Integrative Biology, University of Trento
• Gastroenterology, University of Verona

Cell cultures and co-cultures (Mesenchymal Stromal Cells, PBMC, Neutrophils, Ag-specific Lymphocytes, cancer cell lines); single colony isolation; migration and invasion assays; differentiation and cytotoxicity assays; immunomodulation assay; ELISA; proliferation assays; flow-cytometry; magnetic and fluorescence-activated cell sorting; molecular biology (DNA and RNA extraction, retro transcription, PCR and RT-qPCR); immunofluorescence; western-blot; master and working cell bank production; soft agar; micronucleus assay; colony-forming units; environmental monitoring; endotoxin testing; mycoplasma detection.

LTCA provides its expertise to third parties. Thanks to specific agreements with ULSS8 Berica, several collaborations have been started in the field of research, development and consultancy.